A carregar...
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
Background. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous antiangiogenic hormone with anticancer activity. In a phase I study of Ang-(1-7), two of three patients with metastatic sarcoma experienced disease stabilization. This phase II study examined clinical and biomarker outcomes for patients with...
Na minha lista:
| Publicado no: | Sarcoma |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118533/ https://ncbi.nlm.nih.gov/pubmed/27895527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4592768 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|